Background MIGS have been developed as a surgical alternative for glaucomatous patients.
Purpose To analyze the change in intraocular pressure (IOP) and glaucoma medications …

Monoclonal antibodies (mAbs) are one of the most important classes of therapeutic proteins,
which are used to treat a wide number of diseases (eg, oncology, inflammation and …

Purpose Evaluate the safety and effectiveness of an ab interno implanted (iStent inject)
Trabecular Micro-Bypass System (Glaukos Corporation, San Clemente, CA) in combination …

Micro-or minimally invasive glaucoma surgeries (MIGS) have been the latest addition to the
glaucoma surgical treatment paradigm. This term refers not to a single surgery, but rather to …

Purpose Evaluate long-term outcomes after one, two, or three trabecular micro-bypass
stents implanted in a standalone procedure in eyes with open-angle glaucoma taking ocular …

Introduction This study evaluates long-term outcomes of two trabecular micro-bypass stents,
one suprachoroidal stent, and postoperative prostaglandin in eyes with refractory open …

Microinvasive glaucoma surgery (MIGS) is emerging as a new therapeutic option for
glaucoma patients who wish to reduce their medication burden and avoid the postoperative …

Background To compare real‐world 24‐month outcomes of phacoemulsification combined
with either iStent inject or Hydrus Microstent. Methods Analysis of data from the Fight …

Introduction In this real-world, retrospective, comparative study we evaluated 6-month
performance and safety in consecutive eyes following implantation of the iStent® or iStent …

Introduction This retrospective consecutive case series assessed 12-month effectiveness
and safety of iStent® or iStent inject® trabecular micro-bypass implants with cataract surgery …